Plasma histamine and hemodynamic responses following administration of nalbuphine and morphine
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
A comparative study of plasma histamine levels following administration or morphine and nalbuphine in pentobarbital anesthetized dogs was performed. Two concentrations, 3 mg/kg and 0.3 mg/kg of these drugs were investigated. High dose morphine caused an immediate marked increase in plasma histamine from 5.0±0.4 to 340±72 ng/ml. Simultaneous with this increase in plasma histamine was a marked decrease in mean arterial blood pressure within the first minute. In contrast significant alterations in plasma histamine levels were not observed with high or low doses of nalbuphine. A low dose of morphine (0.3 mg/kg) did not increase plasma histamine levels. Heart rate was not changed by any drug treatment. The use of compound 48/80 a specific mast cell degranulating agent allowed for the identification of a specific pool of mast cells capable of responding to morphine.In vitro exposure of purified dog leukocytes to high doses of morphine did not result in histamine release. These results indicate that nalbuphine does not increase plasma histamine, while morphine does, and that the source of the increase in plasma histamine is from tissue mast cells.
- E. Lowenstein, P. Hallowell, F.H. LeVine, W.M. Daggett, W.G. Austen andM.B. Laver,Cardiovascular response to large doses of intravenous morphine in man, New Engl. J. Med.281, 1389–1393 (1969).
- T.H. Stanley, N.H. Gray, W. Stanford andR. Armstrong,The effect of high dose morphine on fluid and blood requirements in open heart operations, Anesthesiology38, 536–541 (1973).
- K.C. Wong, W.E. Martin, T.F. Horbein, F.G. Freund andJ. Everett,The cardiovascular effect of morphine with oxygen and with nitrous oxide in man, Anesthesiology38, 541–549 (1973).
- T.H. Stanley andL.R. Webster,Anesthetic requirement and cardiovascular effect of fentanyl oxygen and fentanyl diazepam oxygen anesthesia in man, Anesth. Analg. (Cleve)57, 411–416 (1978).
- J.E. Eckenhoff andS.R. Oech,The Effects of narcotics and antagonist upon respiration and circulation in man, Clin. Parmac. Ther.1, 483–524 (1960).
- C.E. Rosow, J. Moss, D.M. Philbin andJ.J. Savarese,Histamine release during morphine and fentanyl anesthesia, Anesthesiology56, 93–96 (1982).
- C.L. Lake, E.N. Duckworth, C.A. DiFazio, C.G. Durbin andM.R. Magruder,Cardiovascular effects of nalbuphine in patients with coronary or valvular heart disease, Anesthesiology37, 498–503 (1982).
- R.P. Siraganian,An automated continuous-flow system for the extraction and fluorometric analysis of histamine, Analyt. Biochem.57, 383–394 (1974).
- R.P. Siraganian, Histamine release and assay methods for the study of human allergy. InManual of Clinical Immunology, pp. 603–625. (Eds.N.R. Rose andH. Friedman) American Society for Microbiology, Washington, DC 1976.
- C.D. May, M. Lyman, R. Alberto andF. Cheng,Procedures for immunochemical study of histamine release from leukocytes with small blood volume, J. Allergy46, 12–20 (1970).
- J.E. Schurig, R.L. Cavanagh andJ.P. Buyniski,Effect of butorphanol and morphine on pulmonary mechanics, arterial blood pressure and venous plasma histamine in the anesthetized dog, Archs. int. Pharmacodyn. Thér.233, 296–304 (1978).
- D.M. Philbin, J. Moss, C.W. Akins, C.E. Rosow, K. Kono, R.C. Schneider, T.R. VerLee andJ.J. Savarese,The use of H 1 and H 2 histamine antagonists with morphine anesthesia: a double-bind study, Anesthesiology55, 292–296 (1981).
- W. Lorenz, H. Barth, M. Thermann, A. Schmal, P. Dormann andI. Niemeyer,Fluorometric histamine determination in canine plasma under normal conditions, following application of exogenous histamine, and during histamine release by Haemaccel, Hoppe-Seyler's Z. Physiol. Chem.355, 1097–1111 (1974).
- W. Lorenz, M. Thermann, K. Messmer, A. Schmal, P. Dormann, J. Kusche, H. Barth, R. Tauber, M. Hutzel, G. Mann andR. Uhlig,Evaluation of histamine elimination curves in plasma and whole blood of several circulatory regions: a method for studying kinetics of histamine release in the whole animal, Agents and Actions4, 336–356 (1974).
- D.A.A. Owen, C.A. Harvey andM.J. Boyce,Effects of histamine on the circulatory system, Klin. Wschr.60, 972–977 (1982).
- J.P. Trzeciakowski andR. Levi,Cardiac histamine: a mediator in search of a function, Trends in Pharmacol. Sciences2, 14–17 (1981).
- J.W. Constantine andW.S. Lebel,Histamine release in dogs by Emulphor EL620, Experientia35, 338–339 (1978).
- W. Kazimierczak andB. Diamont,Mechanisms of histamine release in anaphylactic and anaphylactoid reactions, Prog. Allergy24, 295–365 (1974).
- P.B. Dews, A.L. Wnuck, R.V. Fanelli, A.E. Light, J.A. Tornaber, S. Norton, C.H. Ellis andE.J. DeBeer,The pharmacology of 48/80 a long acting vasodepressor drug, J. Pharmac. exp. Ther.107, 1–11 (1953).
- A.N. Smith,Release of histamine by the histamine liberator compound 48/80 in cats, J. Physiol., Lond.121, 517–538 (1953).
- W. Felberg andJ. Talesnik,Reduction of tissue histamine by compound 48/80, J. Physiol. Lond. 20, 550–568 (1953).
- W. Lorenz, J.V. Parkin, H. Rohde, H. Barth, H. Troidl, K. Thon, E. Hinterlang, D. Weber, R. Albrecht andH. Roher, Histamine in gastric secretory disorders: the relevance of the mucosal histamine content and the origin of histamine in gastric aspirate. InGastric Secretion, Basic and Clinical Aspects (EdsS.J. Konturek andW. Domschke). Georg Thieme Verlag, Stuttgart-New York, Thieme-Stratton Inc., New York 1981.
- W. Lorenz, K. Mohri, H.-J. Reimann, H. Troidl, H. Rohde andH. Barth, Intramucosal mechanisms: relevance of the mast cell concept, Inter Congress Series 537,Advances in Ulcer Disease, pp. 177–191. Excerpta Medica, Amsterdam-Oxford-Princeton 1981.
- L. Enerback,Mast cells in rat gastrointestinal mucosa. III. Reactivity towards compound 48/80, Acta Path. Microbiol. Scand.66, 316 (1966).
- F.L. Pearce,Mast cell heterogeneity, Trends in Pharmacol. Sciences4, 165–166 (1983).
- W.D.M. Paton,The release of histamine, Prog. Allergy5, 79–148 (1958).
- W. Lorenz andA. Doenicke,Histamine release in clinical conditions, The Mount Sinai, J. Med.45, 357–386 (1978).
- R.R. Miller,Evaluation of nalbuphine hydrochloride, Am. J. Hosp. Pharm.37, 942–949 (1980).
- W.T. Beaver andG.A. Feise,A comparison of the analgesic effect of intramuscular nalbuphine and morphine in patients with postoperative pain, J. Pharmac. Exp. Ther.204, 487–496 (1978).
- A Romagnoli andA.S. Keats,Ceiling effect for respiratory depression by nalbuphine, Clin. Pharmac. Ther.27, 478–485 (1980).
- G. Lee, R.I. Low, E.A. Amsterdam, A.N. DeMaria, P.W. Huber andD.T. Mason,Hemodynamic effects of morphine and nalbuphine in acute myocardial infaction, Clin. Pharmac. Ther.29, 576–581 (1981).
- S.M. Muldoon, J. Otto, W. Freas andR.L. Watson,The effect of morphine, nalbuphine and butorphanol on adrenergic function in canine saphenous veins, Anesth. Analg.62, 21–28 (1983).
- Plasma histamine and hemodynamic responses following administration of nalbuphine and morphine
Agents and Actions
Volume 15, Issue 3-4 , pp 229-234
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Anesthesiology, Uniformed Services University of the Health Sciences, 20814, Bethesda, MD, USA
- 2. Department of Biochemistry, Armed Forces Radiobiology Research Institute, 20814, Bethesda, MD, USA